An innovative, 15-year study reveals low rates of breast cancer recurrence in patients with reconstructed breast tissue, chest walls or lymph nodes.

Awareness of genetic testing is low, a new study finds. But an interactive website can help newly diagnosed patients make informed decisions about the practice.

Patients feel providers do not adequately address concerns about the cost of cancer treatment, which can heighten anxiety during an already stressful time.

Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.

In a new study of breast cancer patients who had breast reconstruction, researchers examine complications across the different types of surgeries.

Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.